Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis.

Lin F, Shi J, Liu H, Hull ME, Dupree W, Prichard JW, Brown RE, Zhang J, Wang HL, Schuerch C.

Am J Surg Pathol. 2008 Jan;32(1):78-91.

PMID:
18162774
2.

The von Hippel-Lindau tumour suppressor protein: new perspectives.

Ohh M, Kaelin WG Jr.

Mol Med Today. 1999 Jun;5(6):257-63. Review.

PMID:
10366821
3.

S100P: a novel therapeutic target for cancer.

Arumugam T, Logsdon CD.

Amino Acids. 2011 Oct;41(4):893-9. doi: 10.1007/s00726-010-0496-4. Epub 2010 May 28. Review.

4.

The life and works of S100P - from conception to cancer.

Prica F, Radon T, Cheng Y, Crnogorac-Jurcevic T.

Am J Cancer Res. 2016 Jan 15;6(2):562-76. eCollection 2016. Review.

5.

Prevention of pancreatic cancer.

Kuroczycki-Saniutycz S, Grzeszczuk A, Zwierz ZW, Kołodziejczyk P, Szczesiul J, Zalewska-Szajda B, Ościłowicz K, Waszkiewicz N, Zwierz K, Szajda SD.

Contemp Oncol (Pozn). 2017;21(1):30-34. doi: 10.5114/wo.2016.63043. Epub 2017 Mar 22. Review.

Supplemental Content

Support Center